Old Web
English
Sign In
Acemap
>
authorDetail
>
H. I. Kim
H. I. Kim
National Institutes of Health
Toxicity
Medicine
Pathology
Cancer
Pharmacokinetics
3
Papers
381
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report.
1994
Journal of Clinical Oncology
James Chih-Hsin Yang
Suzanne L. Topalian
David R. Parkinson
Douglas J. Schwartzentruber
Jeffrey S. Weber
Stephen E. Ettinghausen
Donald E. White
Seth M. Steinberg
David J. Cole
H. I. Kim
Show All
Source
Cite
Save
Citations (149)
Phase I Trial of Recombinant Human Macrophage Colony-Stimulating Factor Administered by Continuous Intravenous Infusion in Patients With Metastatic Cancer
1994
Journal of the National Cancer Institute
David J. Cole
Martin G. Sanda
James Chih-Hsin Yang
Douglas J. Schwartzentruber
Jaimie L. Weber
Stephen E. Ettinghausen
Barbara A. Pockaj
H. I. Kim
R. D. Levin
H. W. Pogrebniak
Jaikrishna Balkissoon
R. M. Fenton
L. R. Debarge
J. Kaye
Steven A. Rosenberg
David R. Parkinson
Show All
Source
Cite
Save
Citations (26)
Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.
1993
Journal of Clinical Oncology
Jeffrey S. Weber
James Chih-Hsin Yang
Suzanne L. Topalian
David R. Parkinson
D S Schwartzentruber
Stephen E. Ettinghausen
H Gunn
Arnold Mixon
H. I. Kim
David J. Cole
Show All
Source
Cite
Save
Citations (206)
1